Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 8 of 8 for “"Metabolic Vulnerability"”.
-
Metabolic vulnerability in HER2-positive Breast Cancer
… lethal targets. TALDO1, a gene encoding a metabolic enzyme in the non-oxidative pentose phosphate pathway was identified from the screen. Metabolic profiling with isotope-labeled glucose was used to understand the mechanism. The profiling results indicated that TALDO1 was necessary for …
-
Antioxidant Programs Are Essential for Enzalutamide-Resistant Prostate Cancer
… to improve patient outcomes. To identify the metabolic alterations involved in enzalutamide resistance, we performed metabolomic, transcriptomic, and cistromic analyses of enzalutamide-sensitive and -resistant PCa cells, xenografts, patient-derived organoids, patient-derived explants, and …
-
Therapeutic Potential of Prmt5 and Mat2A As Synthetic Lethal Targets In Mtap-Deficient Gbm Tumors
… lung squamous cell carcinoma. MTAP is a critical metabolic enzyme in the methionine salvage pathway responsible for the breakdown of methylthioadenosine (MTA). As a result, <em>MTAP</em>-deleted cells cannot metabolize MTA, leading to the accumulation of MTA. High levels of MTA in …
-
The Identification and Targeting of Altered NAD+ Metabolism in Glioblastoma
… and evaluates multiple strategies to target this vulnerability. We first performed transcriptomic analyses from The Cancer Genome Atlas and Genotype Tissue Expression database and identified multiple enzymes involved in NAD+ synthesis and consumption are upregulated in GBM compared to normal brain …
-
Targeting Metabolic Adaptations to Anti-Angiogenic Therapy In Ovarian Cancer
… inhibitor as a means of exploiting the metabolic vulnerability of glutamine dependence that develops as a result of adaptive resistance to AVA therapy.</p> <p><strong>Experimental Design: </strong>We used a glutaminase inhibitor (GLSi) synthesized at MD Anderson Cancer Center for all …
-
Investigating Therapeutic Strategies to Target Metabolic Vulnerabilities of Nsclc Tumors With Mutant Keap1 Gene
<p>The metabolic vulnerability of cancers has long been envisaged as an attractive window to develop novel therapeutic strategies. Metabolic flexibility at the cellular level encompasses the efficient rerouting of anabolic and catabolic pathways in response to varying environmental stimuli to …